Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Walz

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Urology|June 25, 2019
<sup>68</sup>Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective StudyAndrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
BJU International|April 3, 2012
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus PanelMartijn Smeenge, Jelle Barentsz, David Cosgrove, et al.
European Urology|December 14, 2011
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancerAlberto Briganti, Steven Joniau, Paolo Gontero, et al.
The Journal of Urology|September 17, 2019
Reply by AuthorsAndrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
European Radiology|May 20, 2020
ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' trainingMaarten de Rooij, Bas Israël, Marcia Tummers, et al.
European Urology|February 4, 2014
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studySteven Joniau, Alberto Briganti, Paolo Gontero, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter StudyStefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
BJU International|November 5, 2013
Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus projectBerrend G Muller, Willemien van den Bos, Maurizio Brausi, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Urology|June 25, 2019
<sup>68</sup>Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective StudyAndrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
BJU International|April 3, 2012
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus PanelMartijn Smeenge, Jelle Barentsz, David Cosgrove, et al.
European Urology|December 14, 2011
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancerAlberto Briganti, Steven Joniau, Paolo Gontero, et al.
The Journal of Urology|September 17, 2019
Reply by AuthorsAndrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
European Radiology|May 20, 2020
ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' trainingMaarten de Rooij, Bas Israël, Marcia Tummers, et al.
European Urology|February 4, 2014
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studySteven Joniau, Alberto Briganti, Paolo Gontero, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter StudyStefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
BJU International|November 5, 2013
Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus projectBerrend G Muller, Willemien van den Bos, Maurizio Brausi, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
Pageof 22